Free Trial

Canopy Growth Corp (TSE:WEED) Director David Angelo Lazzarato Sells 3,006 Shares

Canopy Growth logo with Medical background

Canopy Growth Corp (TSE:WEED - Get Free Report) Director David Angelo Lazzarato sold 3,006 shares of the firm's stock in a transaction dated Tuesday, December 31st. The stock was sold at an average price of C$3.84, for a total transaction of C$11,557.47.

Canopy Growth Trading Down 1.2 %

Canopy Growth stock traded down C$0.05 during trading on Monday, hitting C$4.20. The company had a trading volume of 1,527,841 shares, compared to its average volume of 2,055,456. Canopy Growth Corp has a 1-year low of C$3.74 and a 1-year high of C$20.50. The company's 50 day simple moving average is C$5.15 and its 200-day simple moving average is C$7.00. The stock has a market cap of C$356.41 million, a price-to-earnings ratio of -0.53, a price-to-earnings-growth ratio of -0.01 and a beta of 1.79. The company has a current ratio of 2.15, a quick ratio of 2.32 and a debt-to-equity ratio of 117.00.

Analyst Ratings Changes

Separately, ATB Capital lowered Canopy Growth from a "sector perform" rating to an "underperform" rating and lowered their price objective for the stock from C$6.00 to C$4.00 in a research report on Tuesday, December 17th.

Read Our Latest Stock Report on Canopy Growth

Canopy Growth Company Profile

(Get Free Report)

Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names.

Featured Articles

Should You Invest $1,000 in Canopy Growth Right Now?

Before you consider Canopy Growth, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Canopy Growth wasn't on the list.

While Canopy Growth currently has a "Strong Sell" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Transportation Stocks to Watch in 2025: Top Picks for Growth
Crypto Boom 2025: Bitcoin’s Rise and Trump’s Impact on the Market
Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines